Journals | Policy | Permission

Journal of Clinical Medicine Research

Case Report

Volume 7, Number 8, August 2015, pages 646-648

Tracheobronchial Tuberculosis Without Lung Involvement

Endotracheal tuberculosis (ETTB) is defined as granulomatous infection of the tracheobronchial tree with involvement of the bronchial mucosa and submucosa [1]. The normal diagnosis way from patients with active tuberculosis (TB) usually does not require a bronchoscopy as routine procedure. However, Jung and his colleagues recently described that ETTB is present in 50% of patients with active pulmonary TB. They performed the bronchoscopy in 429 TB patients finding 233 endobronchial tuberculosis (EBTB) [2]. EBTB often injures the tracheobronchial wall and leads to tracheobronchial stenosis [3].

The clinical presentation shows non-specific respiratory symptoms or radiologic images. Moreover, 10-20% of cases present with normal chest radiographs [4]. The diagnostic performance of the sputum smear microscopy is usually low and variable [5]; high resolution computed tomography (HRCT) works as a more sensitive tool and shows a classical pattern known as “tree-in-bud”. Fiber-optic bronchoscopy contributes to the evaluation and diagnosis of endotracheal obstructive lesions and the taking of the samples (biopsy or BAL) to the pathologic and bacteriological analyses [6]. However, diagnosis of ETTB remains challenging for clinicians since initially it shows non-specific signs and symptoms.

A 73-year-old man was admitted to the hospital with fatigue, weakness, dry cough and weight loss (around 6 kg) during the last 3 months, without fever or night sweating. He had past medical history of ex-smoker (35 packs/year), hypertension and hypothyroidism. He presented a myelodysplastic syndrome of 3-year progression. When he was 60 years old, he underwent resection of a melanoma in the lower right lobe.

Laboratory evaluation showed low number of leukocytes (1,900/mm³), a hematocrit of 31% and platelet count of 280,000/mm³. LDH was 414 U/L, erythrocyte sedimentation rate (ESR) was 100 mm and CRP was 20 mg/dL. The rest of the laboratory data were normal.

HRCT showed mediastinal and hilar lymphadenopathy with tracheal and right lobe involvement but no lung parenchymal involvement (Fig. 1). Fibrobronchoscopy showed the lower part of the tracheal wall with edema and infiltrates in pavement epithelium; however, tracheal biopsy for acid-fast bacilli and malignant cells was negative (Fig. 2). Symptoms worsened and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) was performed to get samples of lymph nodes. The presence of necrotizing caseous granuloma confirmed the diagnosis of EBTB.

Click for large image

Figure 1. Tomographic images. (a) Normal lung parenchyma observed in different cuts of the HRCT. Commitment in the tracheal lumen with a narrowness in the right bronchus source due to an hilar mass. (b) Mediastinal windows observed in the HRCT. Tracheal bulge and adenomegalies in the mediastinum and hilum were observed.

Click for large image

Figure 2. Bronchial images. (a) Bronchial mucosa edematous. (b) Infiltrated edematous and pavement of bronchial mucosa in the right bronchus source.

Patient was treated with isoniazid (5 mg/kg), rifampicin (10 mg/kg), pyrazinamide (25 mg/kg) and ethambutol (20 mg/kg) orally, during 9 months. Symptoms and serum inflammatory markers improved considerably.

The pathogenesis of EBTB remains poorly understood due to the heterogeneity in the clinical presentation, duration of symptoms and variability of clinical features depending upon the site, extent of involvement, and stage of the disease [3]. Systemic symptoms like anorexia, weight loss, and night sweats might not be prominent in EBTB [7].

Bronchoscopic findings contribute to classify this disease into several subtypes according to Chung classification. It has been previously reported that the therapeutic outcomes of each subtype can be predicted by follow-up bronchoscopy during the initial treatment [8].

Patients with suspicion of EBTB must be diagnosed promptly because they need immediate treatment to avoid development of tracheobronchial stenosis. The goal of treatment is eradication of tubercle bacilli. Corticosteroid therapy for prevention of bronchial stenosis in these patients remains controversial [9-11]. As stenosis from fibrous disease cannot be reversed with steroids or other medication, the only way to regain airway patency is through surgery or endobronchial intervention [12].

EBUS-TBNA is an invasive procedure that allows mediastinal and hilar lymph node assessment with high sensitivity. Currently, its role in the diagnosis of intrathoracic TB is being studied. Sun et al have recently described high sensitivity and specificity of EBUS-TBNA (85% and 100% respectively) in the diagnosis of EBTB [13, 14].

This case presentation reports a patient with a normal chest x-ray whose bronchoscopy showed granular EBTB. The endoscopic images presented granulomas in the tracheobronchial tree; however, the tracheal biopsy was negative. EBUS-TBNA of the lymph nodes is not considered a front-line diagnostic procedure for these cases; however, we present this case with a non-traditional diagnosis way. We decide to use alternatives tool due to EBTB suspicion. In this case, EBUS-TBNA contributed to confirm the presence of tubercle bacilli allowing for prompt treatment and avoiding complications such as tracheobronchial stenosis.

Conflicts of Interest

Authors have no conflicts of interest to declare.

1. Xue Q, Wang N, Xue X, Wang J. Endobronchial tuberculosis: an overview. Eur J Clin Microbiol Infect Dis. 2011;30(9):1039-1044.
   doi pubmed
2. Jung SS, Park HS, Kim JO, Kim SY. Incidence and clinical predictors of endobronchial tuberculosis in patients with pulmonary tuberculosis. Respirology. 2015;20(3):488-495.
   doi pubmed
3. Hoheisel G, Chan BK, Chan CH, Chan KS, Teschler H, Costabel U. Endobronchial tuberculosis: diagnostic features and therapeutic outcome. Respir Med. 1994;88(8):593-597.
   doi
4. Lee JY, Yi CA, Kim TS, Kim H, Kim J, Han J, Kwon OJ, et al. CT scan features as predictors of patient outcome after bronchial intervention in endobronchial TB. Chest. 2010;138(2):380-385.
   doi pubmed
5. Lee JH, Park SS, Lee DH, Shin DH, Yang SC, Yoo BM. Endobronchial tuberculosis. Clinical and bronchoscopic features in 121 cases. Chest. 1992;102(4):990-994.
   doi pubmed
6. Kashyap S, Solanki A. Challenges in endobronchial tuberculosis: from diagnosis to management. Pulm Med. 2014;2014:594806.
   doi pubmed
7. Van den Brande PM, Van de Mierop F, Verbeken EK, Demedts M. Clinical spectrum of endobronchial tuberculosis in elderly patients. Arch Intern Med. 1990;150(10):2105-2108.
   doi pubmed
8. Chung HS, Lee JH. Bronchoscopic assessment of the evolution of endobronchial tuberculosis. Chest. 2000;117(2):385-392.
   doi
9. Senderovitz T, Viskum K. Corticosteroids and tuberculosis. Respir Med. 1994;88(8):561-565.
   doi
10. Toppet M, Malfroot A, Derde MP, Toppet V, Spehl M, Dab I. Corticosteroids in primary tuberculosis with bronchial obstruction. Arch Dis Child. 1990;65(11):1222-1226.
    doi pubmed
11. Park IW, Choi BW, Hue SH. Prospective study of corticosteroid as an adjunct in the treatment of endobronchial tuberculosis in adults. Respirology. 1997;2(4):275-281.
    doi pubmed
12. Nakamoto K, Maeda M. [Tracheobronchoplasty for endobronchial tuberculosis]. Kekkaku. 1991;66(11):789-792.
    pubmed
13. Senturk A, Arguder E, Hezer H, Babaoglu E, Kilic H, Karalezli A, Hasanoglu HC. Rapid diagnosis of mediastinal tuberculosis with polymerase chain reaction evaluation of aspirated material taken by endobronchial ultrasound-guided transbronchial needle aspiration. J Investig Med. 2014;62(6):885-889.
    pubmed
14. Sun J, Teng J, Yang H, Li Z, Zhang J, Zhao H, Garfield DH, et al. Endobronchial ultrasound-guided transbronchial needle aspiration in diagnosing intrathoracic tuberculosis. Ann Thorac Surg. 2013;96(6):2021-2027.
    doi pubmed

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Journal of Clinical Medicine Research is published by Elmer Press Inc.